Literature DB >> 19268762

High incidence of venous thrombosis after surgery for abdominal aortic aneurysm.

Emmanuel de Maistre1, Beatrice Terriat, Anne-Sophie Lesne-Padieu, Nicolas Abello, Olivier Bouchot, Eric F Steinmetz.   

Abstract

OBJECTIVE: The incidence of venous thromboembolism (VT) after aortic abdominal aneurysm (AAA) surgery is imprecisely reported. On one hand, thromboprophylaxis has improved, on the other hand, AAA patients have become older and/or present worse comorbidities. Herein, we prospectively analyzed the incidence of VT in a continuous series of patients operated on for AAA repair and looked for predictive factors.
MATERIALS AND METHODS: Between January 1, 2005, and December, 31, 2006, 193 consecutive patients (177 men and 16 women), mean age 73 (range, 47-93) underwent elective AAA repair, 137 open (71%) and 56 endovascular (29%), in our institution. Thromboprophylaxis consisted of thigh-length compression bandages or stockings, early mobilization, and a daily subcutaneous injection of low-molecular-weight heparin (enoxaparin 40 mg per day). Patients with renal insufficiency or aged over 80 were given unfractionated heparin (5000 IU twice a day). Heparin was started between day 1 and day 5 (median = day 1) after surgery, according to the prescription of the surgeon. A bilateral lower limb duplex venous compression ultrasonography scan using 3 to 7.5 MHz transducers was systematically done before and after surgery in each patient. Two groups were considered: group 1 with postoperative VT (n = 17) and group 2 without (n = 176). The 17 patients with VT were compared with 51 patients randomly chosen among the 176 patients without VT. Different characteristics such as venous risk factors, preoperative antithrombotic treatment, anatomical features of the AAA, and perioperative data were studied.
RESULTS: Seventeen patients (8.1%) were diagnosed with postoperative VT (15 asymptomatic deep vein thrombosis [DVT] and 2 symptomatic pulmonary embolisms [PE]). VTE tended to be more frequent in open (10.2%) than endovascular (5.3%) repair (P = .28). Among perioperative data, delay to thromboprophylaxis was related to bleeding complication (P = .05) and blood transfusion (P = .02), and tended to be longer in VT patients (1.7 +/- 1.4 vs 0.9 +/- 0.9 day; P = .09).
CONCLUSION: Despite systematic prevention with heparin, surgery for AAA repair induces a high incidence of postoperative VT. This series mandates for vigilance about VT, with particular attention to the patients who received transfusion with fresh frozen plasma. Even though this series is one of the largest ever published on this topic, the rarity of the events calls for confirmation with a larger prospective study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268762     DOI: 10.1016/j.jvs.2008.10.005

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

1.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Use of blood products and risk of stroke after coronary artery bypass surgery.

Authors:  Reija Mikkola; Jarmo Gunn; Jouni Heikkinen; Jan-Ola Wistbacka; Kari Teittinen; Kari Kuttila; Jarmo Lahtinen; Tatu Juvonen; Juhani Ke Airaksinen; Fausto Biancari
Journal:  Blood Transfus       Date:  2012-02-22       Impact factor: 3.443

3.  The association of venous thromboembolism chemoprophylaxis timing on venous thromboembolism after major vascular surgery.

Authors:  Danielle C Sutzko; Patrick E Georgoff; Andrea T Obi; Mark A Healy; Nicholas H Osborne
Journal:  J Vasc Surg       Date:  2017-09-01       Impact factor: 4.268

4.  Risk factors for venous thromboembolism after vascular surgery and implications for chemoprophylaxis strategies.

Authors:  Zachary A Matthay; Colleen P Flanagan; Katherine Sanders; Eric J Smith; Elizabeth M Lancaster; Warren J Gasper; Lucy Z Kornblith; Jade S Hiramoto; Michael S Conte; James C Iannuzzi
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2021-10-09

5.  A rare coexistence of acute thrombotic occlusion of the left popliteal-tibioperoneal artery and the left iliofemoral vein: a case report.

Authors:  Seyhan Yilmaz; Sabur Zengin
Journal:  Arch Med Sci Atheroscler Dis       Date:  2022-03-28

6.  Impact of screening versus symptomatic measurement of deep vein thrombosis in a national quality improvement registry.

Authors:  Randall R De Martino; Adam W Beck; Matthew S Edwards; Matthew A Corriere; Jessica B Wallaert; David H Stone; Jack L Cronenwett; Philip P Goodney
Journal:  J Vasc Surg       Date:  2012-07-24       Impact factor: 4.268

Review 7.  The Abdominal Aortic Aneurysm and Intraluminal Thrombus: Current Concepts of Development and Treatment.

Authors:  Aleksandra Piechota-Polanczyk; Alicja Jozkowicz; Witold Nowak; Wolf Eilenberg; Christoph Neumayer; Tadeusz Malinski; Ihor Huk; Christine Brostjan
Journal:  Front Cardiovasc Med       Date:  2015-05-26

8.  Pulmonary Embolism due to Inferior Vena Cava Compression by a Retroperitoneal Hematoma after Endovascular Repair of a Ruptured Abdominal Aortic Aneurysm.

Authors:  Kota Shukuzawa; Naoki Toya; Yasutake Momokawa; Soichiro Fukushima; Tadashi Akiba; Takao Ohki
Journal:  Case Rep Vasc Med       Date:  2017-05-17

9.  Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with aortic aneurysms: A nationwide cohort study.

Authors:  Feng-You Lee; Wei-Kung Chen; Chun-Hsiang Chiu; Cheng-Li Lin; Chia-Hung Kao; Chao-Hsien Chen; Tse-Yen Yang; Ching-Yuan Lai
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

Review 10.  Interventions for preventing venous thromboembolism following abdominal aortic surgery.

Authors:  M G Bani-Hani; H Al-Khaffaf; M A Titi; I Jaradat
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.